Results 31 to 34 of about 35 (34)
Topics of Interest in Women With Myeloproliferative Neoplasms
American Journal of Hematology, Volume 100, Issue S4, Page 74-87, June 2025.Women with MPN: life‐cycle phases, specific risks, and influencing factors. ABSTRACT Overview Sex and gender have emerged as central modifiers of disease biology, phenotype, and clinical outcomes in myeloproliferative neoplasms (MPNs). This review will uniquely highlight issues affecting women with MPN and articulate their relevant determinants ...
Natasha Szuber +2 more
wiley +1 more source
Journal of Clinical Apheresis, Volume 40, Issue 3, June 2025.ABSTRACT Hemoglobin S (HbS) polymerization inhibitor drugs such as voxelotor can result in a split peak in HbS as well as additional peaks with hemoglobin A in quantitative methods of HbS measurement. It is unclear how these results should be used to make transfusion decisions.
Sally Campbell‐Lee +5 more
wiley +1 more source
Sickle Cell Disease in Africa: SickleInAfrica Registry in Ghana, Nigeria and Tanzania
eJHaem, Volume 6, Issue 3, June 2025.ABSTRACT Introduction Sickle cell disease (SCD) is most prevalent in Sub‐Saharan Africa (SSA), where incomplete patient profiles and limited management strategies hinder research and healthcare standards. Methods We describe the first large‐scale and multinational assessment of 13,403 SCD patients enrolled from 2017–2021 across 31 facilities in Ghana ...
Jack Morrice +23 more
wiley +1 more source
eJHaem, Volume 6, Issue 3, June 2025.Abstract Introduction The Danish national haemoglobinopathy screening programme offers screening to at‐risk pregnant women. Despite efforts to increase awareness of the screening programme, most women in the target population remain unscreened. In contrast, > 90% of pregnant women in Denmark attend a screening for chromosomal abnormalities by combined ...
Esther Agnethe Ejskjær Gravholt +6 more
wiley +1 more source